Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

APO-ATORVASTATIN TABLET 20 MG

Approval Number

SIN14403P

Drug Name

APO-ATORVASTATIN TABLET 20 MG

Product Name

APO-ATORVASTATIN TABLET 20 MG

Approval Date

September 5, 2013

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

C10AA05

ATC Item Name

atorvastatin

Manufacturer Information

Pharmaceutical Manufacturer

PHARMAFORTE SINGAPORE PTE LTD

Manufacturers

APOTEX INC.

APOTEX INC. (Etobicoke Site)

Active Ingredients

Ingredient Name

ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE 22MG EQV ATORVASTATIN

Strength

20 MG

Drug MonographAtorvastatin

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy